We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. You can read more about our cookie policy here

Tag: LAB282


Evotec AG: LAB282 awarded first projects

Oxford University and Evotec’s drug discovery partnership launched last November to accelerate drugs to market begins making awards. Hamburg, Germany, 21 February 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) is pleased to announce that LAB282, the £13m drug discovery partnership with Oxford University, has made its first wave of awards, backing projectsaaa

Read more